Allyson Tighe is a Co-Founder and Investor at Amplitude Ventures, a capital catalyst for highly innovative companies at the point of value acceleration. Amplitude works with promising Canadian healthcare companies that share their vision of bringing groundbreaking technologies to patients with a focus on building world-class Canadian companies in precision medicine and next-generation medical devices.
Allyson is also a former medical device entrepreneur and health technology commercialization advisor committed to advancing great science and passionate about creating, building, and growing world class healthcare companies in Canada. She was previously an investor at the BDC Healthcare Fund where their team managed $270 million in capital with investments in the drug, devices, diagnostics and digital health sectors. Prior to joining BDC, Allyson worked as Business Development Manager at the Centre for Drug Research and Development in Vancouver.
Allyson holds a Bachelor in Science in Genetics and a Masters in Science in Physiology, both from Western University, and an MBA from the Richard Ivey School of Business.